Skip to content

A multi-center study of relevance of emerging SEIZURES of unknown etiology and neuronal auto-Antibodies (SEIZURES-Ab)

A multi-center study of relevance of emerging SEIZURES of unknown etiology and neuronal auto-Antibodies (SEIZURES-Ab)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068181
Enrollment
Unknown
Registered
2023-02-09
Start date
2023-02-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune encephalitis and epilepsy

Interventions

Observation group:N/A

Sponsors

Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Agree and sign informed consent; (2) patients aged 5-80 years; (3) Previous health, no history of seizures, new seizures within one year, and the frequency of seizures =1; (4) APE2=4; (5) Complete clinical, EEG, MRI and other characteristic data; (6) Blood and cerebrospinal fluid tested positive for neuronal autoimmune antibodies by TBA+CBA method.

Exclusion criteria

Exclusion criteria: (1) Epilepsy caused by fetal and perinatal brain injury; (2) genetic, brain tumor, brain trauma, cortical dysplasia, cerebrovascular disease, neurodegenerative disease, metabolic or / And toxic encephalopathy, systemic or primary central nervous system (CNS) vasculitis caused by/associated epilepsy or seizures (e.g If there is relevant evidence, start the corresponding diagnosis and treatment). (3) Herpesviridae, enterovirus, respiratory virus, JC virus, measles virus, Japanese encephalitis virus B, HIV disease Encephalitis/brain caused by mycobacterium, syphilis, fungi, mycoplasma, toxoplasma, cryptococcus and other microorganisms Disease; (4) Seizures associated with metabolic causes such as abnormal blood glucose, sodium, liver and kidney function; (5) patients with incomplete data and lost follow-up; (6) Those who have not signed the informed consent.

Design outcomes

Primary

MeasureTime frame
clinical features;EEG features;MRI;Frequency of seizures;mRS score;CASE score;

Countries

China

Contacts

Public Contacthanxiong

Henan Provincial People's Hospital

shengyiHX123@163.com13837171615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026